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Summary SR 4233 (3-amino-1,2,4-benzotriazine-1,4-dioxide) is the lead compound of the benzotriazene-di-N
oxides which are selectively toxic to tumour cells under hypoxic conditions. However much higher concentra-
tions given to rats caused bone marrow toxicity and necrosis of the low oxygen Zone 3 part of the liver. In the
following effects of SR 4233 on hepatocytes under hypoxic vs aerobic conditions have been compared. (1) SR 4233 did not affect hepatocyte viability (as determined by plasma membrane disruption) or
glutathione levels under aerobic conditions. SR 4233 however induced cyanide-resistant respiration, an
indicator of redox cycling mediated oxidative stress and became cytotoxic if hepatocyte catalase or glutathione
reductase was inactivated. Glutathione oxidation occurred well before cytotoxicity ensued. Addition of
ascorbate markedly enhanced SR 4233 cytotoxicity to these compromised hepatocytes.
(2) In contrast, SR 4233 was highly toxic to hypoxic hepatocytes. Addition of ascorbate to enhance SR 4233
reduction also caused a marked increase in hepatocyte toxicity and an SR 4233 radical was detected with ESR
spectroscopy. SR 4233 cellular reduction and toxicity was prevented with fructose or inhibitors of
NADPH:cytochrome P-450 reductase. Inactivation of catalase or glutathione reductase had no effect on SR
4233 toxicity and hepatocyte GSH was not oxidised indicating oxidative stress did not occur during hypoxic
SR 4233 hepatocyte toxicity.
(3) The lack of SR 4233 cytotoxicity under aerobic conditions could probably be attributed to the
detoxification of the SR 4233 radical by mitochondrial oxidation as SR 4233, but not its metabolite SR 4317
markedly increased state III and IV mitochondrial respiration in the presence of NADH. The increased
respiration was inhibited by the respiratory inhibitors KCN and antimycin A but not by rotenone. Further-
more SR 4233 cytotoxicity under aerobic conditions was markedly increased by partially inhibiting
hepatocytes respiration with cyanide but not rotenone.
Over the past two decades there has been a growing effort to
develop compounds which are selectively toxic towards radia-
tion resistant hypoxic tumour cells. Hypoxic cell fractions,
believed to be present in mammalian solid tumours, are
thought to be the reason for the unsuccessful ability to cure
some human malignancies by radiotherapy (Moulder &
Rockwell, 1987). The benzotriazine di-N-oxide, SR 4233 (3-
amino-1,2,4-benzotriazine-1,4-dioxide) is the lead compound
of a new series of hypoxic cell cytotoxins currently being
investigated as anticancer drugs (Zeman et al., 1989). It is up
to 150 times more effective at preventing colony formation if
the tumour cells were treated with SR 4233 under hypoxic
conditions than under aerobic conditions in vitro (Zeman et
al., 1986) suggesting that it may be useful in radiation
therapy. Recently this has been attributed to chromosome
breaks and DNA double strand breaks which are difficult to
repair (Wang et al., 1992).
Although the molecular mechanism of toxicity is still being
debated it has been proposed that a free radical formed by a
one-electron reduction of SR 4233 is the toxic species (Baker
et al., 1988; Laderoute et al., 1988) as the two-electron and
four-electron reduction metabolites, SR 4317 and SR 4330
did not prevent colony formation (Baker et al., 1988). Tox-
icity has been postulated to occur via hydrogen abstraction
from DNA and other cell constituents by the one-electron
reduced SR 4233 free radical (Zeman et al., 1986; Baker et
al., 1988) which was presumably detoxified by oxygen. DT-
diaphorase isolated from Walker 256 rat tumour cells, was
shown to detoxify SR 4233 by catalysing two- and four-
electron reduction of SR 4233 (Riley & Workman, 1992).
Recently, White et al. (1992) reported that acute dosing of
laboratory rats with SR 4233 (0.3 mmol kg-') caused bone
marrow toxicity, subcapsular necrosis of the liver as well as
necrosis of the kidney medulla and olfactory epithelium.
Liver necrosis was confined to hepatocytes of zone 3. The
pericentral (Zone 3) area of the liver lobules experience
oxygen tensions only in the 2-4% range and hepatocytes at
this oxygen tension have been shown to readily metabolise
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SR 4233 to the stable mono-N-oxide via the radical
intermediate (Costa et al., 1989). Furthermore enzymology
studies with rat liver microsomes and NADPH have imp- licated cytochrome P-450 and NADPH:cytochrome P-450
reductase as the major hepatic reductases responsible for the
bioactivation of SR 4233 (Walton & Workman, 1990: Wal-
ton et al., 1989; Lloyd et al., 1991).
In the following, isolated hepatocytes were chosen as the
nonproliferating model target cell using plasma membrane
damage as an endpoint. It was found that the resistance of
hepatocytes under aerobic conditions to SR 4233 could be
attributed to detoxification of the SR 4233 radical by mitochondrial oxidation. Oxidative stress involving GSH
oxidation and oxygen activation occurred under aerobic con-
ditions, but was not toxic unless hepatocyte catalase or
glutathione reductase was inactivated beforehand. The
marked SR 4233 cytotoxicity to hypoxic hepatocytes could




SR 4233 (3-amino-1,2,4-benzotriazine-1,4-dioxide) was ob-
tained from Dr A.M. Rauth, Ontario Cancer Institute, Toronto, Ontario, Canada and from Dr J.R. Milligan,
University of California, CA. SR 4317 (3-amino-1,2,4-
benzotriazine-l-N-oxide) and SR 4330 (3-amino-1,2,4-
benzotriazine-1) were obtained from Dr M. Tracy, SRI Inter-
national, Menlo Park, CA. BCNU was a gift from Bristol-
Myers Laboratories (Syracuse, N.Y.). Trypan blue, t-butyl
hydroperoxide, metyrapone, KCN, GSH, GSSG and sodium
azide were obtained from Sigma (St. Louis, MO). Col-
lagenase (from Clostridium histoliticum) and HEPES were
purchased from Boehringer-Mannheim (Montreal, Quebec).
SKF-525A was a gift from Smith Kline Beecham (Oakville,
Ontario). Other chemicals were of highest grade available
commercially.
Br. J. Cancer (1993), 68, 484-491 '." Macmillan Press Ltd., 1993MECHANISMS OF SR 4233 TOXICITY 485
Animals
Male Sprague-Dawley rats (body wt 220-270 g) fed a stan-
dard chow diet and tap water ad lib were used to prepare
hepatocytes.
Isolation and incubation ofthe hepatocytes
Rat hepatocytes were prepared by collagenase perfusion of
the liver as previously described by Moldeus et al. (1978).
Routinely, 85-95% of the freshly isolated hepatocytes ex-
cluded Trypan blue (Trypan blue concentration: 0.2% w/v).
The cells were suspended in Krebs-Henseleit buffer contain-
ing 12.5 mM HEPES under an atmosphere of 10% 02, 85%
N2 and 5% CO2 for 30 min in continuously rotating round
bottomed 50 ml flasks at 37°C. The final incubation volume
was 10 ml with a concentration of 106cells ml-'. For
experiments performed under hypoxic conditions, the cells
were incubated under an atmosphere of 95% N2 and 5%
CO2 following preincubation (30min) under aerobic condi-
tions. The oxygen concentration in the cellular medium was
<0.1% 30min after the switch to the hypoxic atmosphere
and at this time the experiments were started. SR 4233 and
its metabolites were dissolved in dimethyl sulfoxide and
added in a final concentration of 0.5% (v/v). The control
incubation contained 0.5% (v/v) dimethyl sulfoxide alone.
To inactivate catalase (EC 1.11.1.6) and glutathione reduc-
tase (EC 1.6.4.2), sodium azide (final concentration, 4mM)
and BCNU (final concentration: 50 jM) were added respec-
tively to the cells 15 min prior to the start of the experiment
(Rossi et al., 1989; Babson & Reed, 1978). Azide and BCNU
were not cytotoxic at these concentrations. To oxidise cel-
lular NADPH, t-butyl hydroperoxide (final concentration:
50jIM) was added to hypoxic cells 5 min prior to the start of
the experiment (Rush & Alberts, 1986). NADPH levels at
this time were decreased by >95% as measured by an
HPLC method described by Stocchi et al. (1984) and stayed
depressed for the duration of the experiment. To inactivate
NADPH:cytochrome P-450 reductase, diphenylene iodonium
(final concentration: 501iM) or acrolein (final concentration:
1I00 iM) was added 20 min prior to the start of the experi-
ment (Doussiere & Vignais, 1992; Patel et al., 1984). To
inhibit cytochrome P-450, SKF-525A (final concentration:
100pM) or metyrapone (final concentration:1 mM) was
added to the cells 10 min prior to the start of the experiment
(Netter, 1962). To inactivate DT-diaphorase, dicumarol (final
concentration: 10 jM) was preincubated for 10 min (Ernster
et al., 1960; Rossi et al., 1989). All enzyme modifiers were
maintained in the cell medium throughout the experiment
and were not cytotoxic at the concentrations used.
Microsomal and mitochondrial preparation
Microsomes and mitochondria were isolated from rat liver as
previously described (Ernster et al., 1962; Cain & Skilleter,
1987) and kept cold on ice before use. Protein determination
was measured by the Bradford method (Bradford, 1976).
Assays
Hepatocyte viability was assessed by the Trypan blue dye
exclusion test in a Neubauer chamber, by light microscopy.
Statistical significance of differences between treated and
nontreated groups in these studies were determined by the
two-tailed Student t-test. The criterion of significance chosen
was P<0.05.
Total GSH and GSSG in the hepatocyte incubation mix-
ture were measured by HPLC analysis in deproteinated sam-
ples (5% metaphosphoric acid) after derivatisation with
iodoacetic acid and fluoro-2,4-dinitrobenzene using a ji-
Bondapak NH2 column (Waters Model, MA) as described
(Reed et al., 1980). GSH and GSSG were used as external
standards. A Waters Model 6000A solvent delivery system,
equipped with a Waters Model 660 solvent programmer, a
WISP 710A automatic injector, and a data module, was used
for analysis.
Oxygen consumption was measured by a Clark-type elec-
trode (Model 5300; Yellow-Spring Instrument Co., Inc.) in a
2 ml incubation chamber maintained at 37°C. Prior to
oxygen consumption measurements, hepatocytes (106 cells
ml-') were kept at 37°C in Krebs Henseleit buffer, plus
HEPES (12.5 mM), pH 7.4 under s stream of 10% 02, 85%
N2 and 5% CO2. KCN (2 mM, neutralised with HCI) was
added to inhibit mitochondrial respiration. Measurement of
isolated mitochondrial respiration was performed with rat
liver mitochondria (1 mg ml-') suspended in a respiration
buffer containing 0.25 mM sucrose, 5 mM KH2PO4, 10mM
KCI, 5 mM MgCl2 and 10 mM Tris-HCI at pH 7.4. The res-
piratory control ratio (1kCR) defined as the ratio of oxygen
consumption in the presence (state 3) and absence (state 4) of
ADP (200jiM), when the substrate concentration is not
limiting, was determined by dividing state 3 over state 4
respiration.
Samples for ESR measurements were prepared by the
addition of ascorbate (1OmM) to SR 4233 (2 mM) in 0.1 M
borax buffer, pH 10, previously bubbled with nitrogen for
10 min. The sample was aspirated into a flat cell and ESR
spectra recorded (Mason, 1984). The spectra was scanned
several times (usually 8 min scans). The ESR measurements
were performed in an aqueous flat cell (8 mm wide) using a
TE cavity at room temperature with a Varian E-6 ESR
spectrophotometer.
The reduction of SR 4233, and the formation of SR 4317
and SR 4330 in hepatocytes was carried out by HPLC
analysis as described by Walton and Workman (Walton &
Workman, 1988). Briefly, aliquots (200 jl) of cell samples
from the incubation medium (106 cells ml-') were treated
with 2 vol of ice cold methanol and centrifuged at 3000g for
10 min. Supernatant samples were removed and kept at 4°C
until injected (100 il) into the HPLC system for analysis
(samples were analysed within 2 h). The isocratic reverse
phase chromatography system used comprised of a Beckman
llOB pump, a UV detector ERC-7210, a Pharmacia chart
recorder, a ji-Bondapak phenyl Rad-Pak column (10 cm x
8 mm, 10-Am beads) under pressure from a Z-module which
was protected by a Resolve Cyanopropyl (CN) Guard-Pak
precolumn. The mobile phase used was 33% methanol/67%
deionised water at a flow rate of 2.5 ml min-'. SR 4233, SR
4330 and SR 4317 eluted at 3.4, 5.8 and 7 min, respec-
tively.
Results
As shown in Table I, SR 4233 (150jiM) added to hepatocytes
under 95% N2/5% CO2 caused 100% cell death within a 2 h
incubation period as determined by the Trypan blue ex-
clusion test. The viability of untreated hepatocytes incubated
under these conditions was not affected. However, under an
aerobic environment (10% 02, 85% N2 and 5% C02), SR
4233 (concentration as high as 2 mM) did not affect
hepatocyte viability during the 3 h incubation period.
SR 4233 was cytotoxic under an aerobic environment only
when the cell's defence system against oxidative stress was
compromised by inactivating hepatocyte catalase with azide
or glutathione reductase with BCNU beforehand. As shown
in Table I, 1 mM SR 4233 incubated with catalase inactivated
or glutathione reductase inactivated hepatocytes caused 78
and 100% cell death, respectively, after a 3 h incubation.
Addition of ascorbate to reduce SR 4233 extracellularly
markedly increased SR 4233 cytotoxicity towards catalase-
inactivated hepatocytes by at least 10-fold (Table I). SR 4233
and ascorbate were not however cytotoxic to normal
hepatocytes under aerobic condition. In contrast, under
hypoxic conditions, ascorbate increased the susceptibility of
normal hepatocytes to SR 4233 and inactivation of catalase
or glutathione reductase did not affect hepatocyte suscep-
tibility. Ascorbate by itself was not cytotoxic under hypoxic
conditions. These results confirm the selective toxicity of SR
4233 for hypoxic cells and suggests that the cytotoxic486 J.M. SILVA & P.J. O'BRIEN
Table I SR 4233-induced hepatocyte cytotoxicity under aerobic and hypoxic
environments
Cytotoxicity
(% Trypan blue uptake)
Treatment Min 60 120 180
Aerobic conditions
None 13 2 17 3 18 3
SR 4233 (2mM) 13±2 19±3 21±3
SR 4233 (lmM)+azide 25±4 38±4 78±5a
Azide 13±2 18±3 21 3
SR 4233 (I mM) + BCNU 36 4 78 5 iooa
BCNU 14±2 18±3 22±3
SR 4233 (150gM)+ azide + ascorbate 41 4 85 6 100
SR 4233 (150JAM)+KCN 46±3 60±5 73±7
KCN 17±2 26±3 36±3
Hypoxic conditions
None 15±2 21 3 23±3
SR 4233 (150pM) 37 2 iooa
SR 4233 (100 LM) 24 3 36 ± 4 55 4b
SR 4233 (100;M) + ascorbate 56 4 iooa
SR 4233 (100pM) + azide 25 4 39 4 59 5b
SR 4233 (100jM)+ BCNU 24 4 40 4 61 5b
SR 4233 (100jaM) + DPI 18 2 22 2 28 3
SR 4233 (150pm) + fructose 16 2 21 3 25 3
SR 4233 (150 M) + fructose + monensin 20 ± 3 45 ± 4 86 ± Sa
SR 4233 (150gM)+monensin 39±3 100
Monensin 15 2 22 ± 3 22 3a
Hepatocytes (106 cells ml') were preincubated in Krebs-Henseleit buffer,
pH7.4 at 37°C. Cells were maintained under an aerobic or hypoxic
environment as described in Materials and methods. SR 4233 was then added
to the incubation mixture. Where stated azide (4 mM), monensin (10JiM), DPI
(50 PM), fructose (20 mM) and KCN (400 lAM) were preincubated for 5 min
prior to SR 4233 addition. BCNU (50gM) however, was preincubated for
20 min prior to SR 4233 addition. Cell toxicity was determined as the
percentage ofcells taken up Trypan blue. aSignificantly different from untreated
cells (P <0.001). bSignificantly different from untreated cells (P< 0.02).
70 g a mechanisms for toxicity under aerobic vs hypoxic
environments are different.
60
50 Effect ofSR 4233 on hepatocyte glutathione
Additon of SR 4233 to isolated hepatocytes under either
aerobic or hypoxic conditions did not affect the levels of
0 intracellular GSH (Figure 1). However, intracellular GSH
c \ was oxidised when SR 4233 was added to catalase or
I) 20- \, glutathione reductase inactivated hepatocytes under aerobic
conditions. (Figure 1). Intracellular GSH levels in these com-
10- promised hepatocytes were little affected over the time period
studied in the absence of SR 4233 (results not shown).
0 > , , , Glutathione reductase-inactivated cells had lower initial in-
0 30 60 90 120 tracellular GSH levels due to conjugate formation by a
metabolite of BCNU. Furthermore, the addition of ascorbate
to catalase deficient cells markedly enhanced GSH oxidation
induced by SR 4233 and a 4-fold lower SR 4233 concentra-
70 b tion was effective (Figure 1). Ascorbate by itself had no effect bn on GSH levels in catalase deficient cells under aerobic condi-
, 60- tions. Under hypoxic conditions GSH levels in catalase- o .* I deficient or glutathione reductase inactivated cells were also
not affected by ascorbate (results not shown). .50-
0~
I 40
I 30 3 Figure 1 GSH depletion a, and GSSG formation b, induced by E SR 4233 in isolated hepatocytes under aerobic conditions. C
o g ,y Hepatocytes (106cellsml-') were incubated alone or with 2 mM 20T SR 4233 (0), with azide (4mM) + SR 4233 (1 mM) (0), with
cn t ~ I -BCNU (50lAM) + SR 4233 (@) and with ascorbate (1OmM) +azide (4mM)+SR 4233 (0.5mM) (G). GSH and
0 30 60 90 120 GSSG levels were determined by HPLC analysis, as described in
'Materials and methods'. Three separate experiments were carried Time (min) out. Points, mean; bars, s.e.MECHANISMS OF SR 4233 TOXICITY 487
SR 4233-dependent oxygen consumption by isolated
hepatocytes and by rat liver microsomes and mitochondria
Even though SR 4233 was not cytotoxic to hepatocytes
under aerobic conditions, cyanide-resistant respiration was
induced in hepatocytes on addition of SR 4233. In order to
investigate the ability of SR 4233 to undergo one-electron
reduction and redox cycle with molecular oxygen, ascorbate
was used to stimulate reduction. As shown in Table II,
addition of ascorbate to reduce SR 4233 was accompanied by
marked oxygen consumption. H202 was formed as addition
of catalase at the end of the experiment caused an immediate
release of oxygen (results not shown).
ESR studies showed that an SR 4233 radical was formed
upon incubation of SR 4233 (2 mM) with ascorbate (10 mM)
at pH 10 under an atmosphere of N2 (Figure 2a). In the
absence of SR 4233 or ascorbate, the radical was not formed
(Figure 2b and c). When the sample in the flat cell was
de-aspirated and exposed to air, the SR 4233 radical
immediately disappeared and was detected again after rebub-
bling the sample with nitrogen. Neither SR 4317 or SR 4330
produced detectable radicals nor stimulated oxygen consump-
tion when added to ascorbate (results not shown).
Addition of SR 4233 to rat liver microsomes in the
presence of NADPH also stimulated oxygen consumption.
Interestingly, incubation of SR 4233 with respiring rat liver
mitochondria induced NADH-dependent state 3 and 4
mitochondrial respiration which was completely inhibited by
KCN and antimycin A but not by rotenone (Table III). SR
4233 or NADH alone did not induce mitochondrial respira-
tion. Also, incubation of mitochondria with either SR 4317
or SR 4330 did not induce any NADH dependent mitochon-
drial respiration. This indicated that metabolites of SR 4233
can act as substrates for the mitochondiral respiratory chain.
Furthermore, this suggests that mitochondria may play a
protective role against SR 4233-induced toxicity in the intact
cell by detoxifying the free radical via the mitochondrial
respiratory chain. In support of this theory SR 4233 became
nearly as cytotoxic to hepatocytes under aerobic conditions
as hepatocytes under hypoxic conditions if a nontoxic con-
centration of KCN (400 iM) was added to partly inhibit
mitochondrial electron transport (Table I). At this KCN
concentration hepatocyte respiration was inhibited 76-78%
(results not shown). Furthermore SR 4233 was not cytotoxic
to hepatocytes treated with rotenone (5 ,UM) to inhibit
mitochondrial respiration as shown in Table III (results not
shown).
Metabolism ofSR 4233 by isolated hepatocytes
HPLC analysis was used to determine the reduction of SR
4233 by isolated hepatocytes under hypoxic conditions. As
shown in Table IV, SR 4233 (150jaM) was rapidly meta-
bolised within 1 h at a rate of 3.4 ± 0.6 mmol min-' 106 cells
to form SR 4317. No SR 4330 was formed during this
incubation period. In aerobic hepatocyte incubations no loss
of SR 4233 occurred during a 1 h incubation period (results
not shown). Addition of SKF-525A or metyrapone, two well
known inhibitors of cytochrome P-450, or the DT-diaphorase
inhibitor, dicumarol (Ernster et al., 1960), had no effect on
the rate of SR 4233 metabolism by hypoxic hepatocytes
suggesting that these two enzymes do not play a major role
in the reduction of SR 4233 by hepatocytes.
NADPH:cytochrome P-450 reductase has been suggested
to be involved in the one-electron reduction of SR 4233 to a
free radical which in the absence of oxygen may be further
reduced to the mono-oxide, SR 4317 (Walton & Workman,
1990; Walton et al., 1989; Lloyd et al., 1991). In order to
investigate this hypothesis in our hypoxic cell model we
monitored SR 4233 reduction in NADPH oxidised
hepatocytes. To oxidise cellular NADPH, a small nontoxic
dose (50pM) of t-butyl hydroperoxide (t-BHP) was added to
the cell incubation mixture prior to SR 4233 addition (Rush
& Alberts, 1986). NADPH levels after this treatment were
depressed by >95% for the duration of the experiment. As
shown in Table IV, the metabolism of SR 4233 by hypoxic
hepatocytes was completely inhibited by the presence of
t-BHP.
As yet no inhibitors of NADPH:cytochrome P-450 reduc-
tase have been successfully used to inactivate the reductase in
intact cells without causing toxicity. However, diphenylene
iodonium which has been recently reported to inactivate
Table II SR 4233-induced oxygen uptake by ascorbate, microsomes,
mitochondria and isolated hepatocytes
Oxygen consumed
Microsomes Hepatocytes
Addition Ascorbate NADPH (nmol min- 10-'6)
(cells) (nmol min ') (nmolmin-' mg-') +KCN
SR4233 500LM 26.4±4.4 16.4 3.5 9.3 1.3
SR4233 250JLM 18.5±2.4 10.5±2.2 4.5 1.4
SR 4233 100 JiM 7.5 ± 1.3 n.d.a n.d.a
Oxygen uptake was measured using a Clarke-type electrode as described in
Materials and methods. SR 4233 was added to either ascrobate (10mM) in 0.1 M
Tris-HCI buffer pH 7.4 alone or to isolated microsomes (1 mgml-') + 1 mM
NADPH at 37°C. SR 4233-induced oxygen uptake in hepatocytes was monitored
in Krebs-Henseleit buffer, containing HEPES (12.5 mM) pH 7.4 at a cell density of
106 cells ml-' and 37°C in the presence of KCN (2 mM). Values are expressed as
means of three separate experiments (± s.e.). aNot determined.
Table III Effect of SR 4233 administration on mitochondrial
respirationa
Treatment State 3 State 4 RCRb
Succinate 76.6 ± 5.9 20.7 ± 2.2 3.7
SR 4233 (250jiM) + NADH (1 mM) 6.5 1.6 3.2 ± 0.5 2.0
SR4233 (500SgM)+NADH (1mM) 12.4±2.1 5.3±0.8 2.3
+KCN(lmM) 0 0
+Antimycin A (51M) 0 0
+Rotenone (5gM) 11.3 ±2.2 5.5 ± 0.9 2.0
SR4317 (250gM)+NADH (1mM) 0 0
SR 4330 (250JiM) + NADH (1 mM) 0 0
anmol oxygen uptake min-' mg-' protein. bRCR, respiratory control
ratio. Note: Experiments were performed as described in Materials and
methods. Values are expressed as the means of three separate experiments






Figure 2 The ESR spectrum of the SR 4233 radical generated in a system (0.1 M borax buffer, pH 10) of (2 mM) and ascorbate
(10 mM) previously bubbled with nitrogen for 10 min. (b), same as in a, but without SR 4233, c, same as in a, but without
ascorbate. The instrumental conditions were: 20-mW microwave power, 12.5 G min- scan rate, 0.5-s time constant, 1.6 G
modulation amplitude, and 5 x 104 receiver gain.
NADPH:cytochrome P-450 reductase provided the enzyme
was preincubated with NADPH (Doussiere & Vignais, 1992),
prevented SR 4233 metabolism (Table IV) and cytotoxicity
(Table I) in hepatocytes. Acrolein has also been reported to
selectively inactivate NADPH:cytochrome P-450 reductase
Table IV Metabolism of SR 4233 by hypoxic isolated
hepatocytes
Rate of SR 4233
disappearance
Addition (nmolmin-m Jl-6 cells)
SR 4233 (150sM) 3.4 0.6
SR 4233 (150pM) + acrolein (100gM) 1.4 ± 0.2a
SR 4233 (150 jLM) + t-BHP (50 gIM) 0
SR 4233 (150 jM)+DPI (501M) 0.8 ± 0.2
SR 4233 (150 mM) + fructose (10mM) 3.2 0.6
Hepatocytes (106 cells ml-') were incubated in Krebs-Henseleit
buffer, containing HEPES (12.5 mM) pH 7.4 at 37'C under hypoxic
conditions. Where stated either acrolein fructose, DPI or t-BHP was
preincubated for approximately 5 min prior to SR 4233 addition.
SR 4233 and the product SR 4233 were measured after 20 min of cell
incubation by HPLC analysis as described in Materials and methods.
Values are expressed as means of three separate experiments ( s.e.).
aSignificantly different from SR 4233 alone (P<0.05).
(Patel et al., 1984). Addition of a non cytotoxic concentra-
tion of acrolein to the hepatocytes also markedly delayed SR
4233 metabolism (Table IV).
Prevention ofSR 4233 cytotoxicity towards hypoxic
hepatocytes
As shown in Table I diphenylene iodonium was the most
effective NADPH:cytochrome P-450 reductase inhibitor used
which prevented SR 4233 cytotoxicity in hypoxic isolated
hepatocytes. Fructose also prevented SR 4233 cytotoxicity.
However as shown in Table IV, SR 4233 reduction by
hepatocytes was not affected. As fructose markedly induces
glycolysis and acidosis in hypoxic hepatocytes (Seglen, 1974)
or perfused liver (Iles et al., 1980) and as an acidotic pH
protects against hypoxic hepatocyte injury (Gores et al.,
1989), the protective effect of acidosis against SR 4233
cytotoxicity was investigated. As shown in Table IV monen-
sin, an agent which catalyses the exchange of Na+ for H+
and equalises intracellular pH to that of extracellular pH
(Gores et al., 1989), prevented fructose protection. Further-
more extracellular acidosis (pH 6.5) prevented SR 4233
cytotoxicity towards hypoxic hepatocytes without affecting
SR 4233 metabolism (results not shown).MECHANISMS OF SR 4233 TOXICITY 489
Discussion
In this paper we confirm that the mechanism of SR 4233-
induced cytotoxicity differs in aerobic vs hypoxic
environments. SR 4233 is shown to be metabolised in
isolated hepatocytes by NADPH:cytochrome P-450 reductase
resulting in cellular toxicity in the absence of oxygen which
can probably be attributed to the SR 4233 radical. However
in the presence of oxygen, SR 4233 was shown to redox cycle
resulting in nontoxic oxidative stress. SR 4233 was also
shown to redox cycle via the mitochondrial electron trans-
port system suggesting a new mechanism for detoxification of
the SR 4233 radical under aerobic condition without oxygen
activation resulting in oxidative stress.
SR 4233 has been suggested to undergo a one electron
reduction by various enzymes including NADPH:cytochrome
P-450 reductase. This generates a free radical which either
undergoes a futile redox cycle with molecular oxygen or
under hypoxia may disproportionate and/or acquire a second
electron via hydrogen abstraction to form a stable nontoxic
mono-oxide, SR 4317 (Laderoute et al., 1988; Walton &
Workman, 1990; Walton et al., 1989; Lloyd et al., 1991). In
the present work ascorbate was also found to be very efficient
at inducing oxygen consumption in the presence of SR 4233
but not the SR 4233 reduction metabolites, SR 4317 or
SR4330. This suggests that SR 4233 is reduced to a free
radical by ascorbate which in the presence of oxygen redox
cycles back to the parent compound hence consuming oxygen
in the process. Addition of catalase at the end of the experi-
ment caused a recovery in oxygen indicating that O2- and
H202 had been formed, presumably from the ascorbate
catalysed SR 4233 reduction. ESR evidence also showed the
production of a free radical signal when ascorbate reduced
SR 4233. Even though we were not able to identify the free
radical obtained from the ESR spectra, a recent study by
Lloyd et al. (1991) identified a nitroxyl radical formed by
incubation of a liver microsomal system containing NADPH
with SR 4233. Moreover, using DMPO spin trap experiments
they also showed that superoxide radicals are formed in the
reaction.
The induction of cyanide-resistant respiration when SR
4233 was added to hepatocytes suggests that hepatocytes are
also able to catalyse the reduction of SR 4233 to a free
radical which in turn redox cycles in the presence of oxygen
thereby exposing the cells to oxidative stress. Mammalian
cells are usually well equipped with a defence mechanism
system against oxidative stress. This system includes enzymes
such as superoxide dismutase, glutathione peroxidase,
glutathione reductase, catalase and reducing agents such as
GSH. Previously, we have shown in isolated rat hepatocytes
that the toxic potency of compounds, such as nitrofurantoin
and diaziquone which undergo intracellular futile redox-
cycling with oxygen to generate H202, was markedly in-
creased if components of the cell's peroxide defence system,
such as catalase, were inhibited (Rossi et al., 1989; Silva &
O'Brien, 1989). Furthermore, H202 added directly to the
incubation medium was toxic only to catalase-inactivated
cells (Rossi et al., 1989). As shown in this paper, SR 4233
toxicity to hepatocytes under aerobic conditions was
observed only when the cell's defence system against
oxidative stress was compromised by either inhibition of
catalase or glutathione reductase. Addition of ascorbate to
catalase-inactivated hepatocytes further increased the suscep-
tibility of these cells to SR 4233-induced cytotoxicity. Under
these conditions intracellular GSH was rapidly oxidised to
GSSG well before cell death occurred. These results indicate
that SR 4233 causes oxidative stress under aerobic condi-
tions. Moreover, HPLC analysis of SR 4233 following
incubation with hepatocyte under aerobic conditions did not
show any loss of the parent compound. This provides further
evidence that SR 4233 undergoes futile redox-cycling in
hepatocytes under an aerobic environment.
Under hypoxic conditions, SR 4233 was at least 50-fold
more toxic to hepatocytes compared to aerobic conditions.
Toxicity occurred without affecting the cell's GSH levels.
Addition of ascorbate to enhance the reduction rate of SR
4233 increased its toxic potency. In contrast to the aerobic
study, inactivation of either catalase or glutathione reductase
under hypoxic conditions did not affect SR 4233 induced
toxicity or intracellular GSH levels. These results suggest that
the mechanism of SR 4233-induced hepatocyte toxicity differs
in aerobic vs hypoxic environments.
HPLC analysis confirmed that SR 4233 is rapidly
metabolised by hypoxic hepatocytes within 1 h of incubation
with the formation of the stable two-electron reduction
metabolite, SR 4317, being the only metabolite observed. SR
4317 added to the hyppxic cells, did not undergo further
reduction or cause any loss in cell viability. SR 4233
metabolism was prevented if cellular NADPH was oxidised
with a pulse of t-butyl hydroperoxide (t-BHP). The latter
oxidises hepatocyte NADPH because glutathione peroxidase
and glutathione reductase are involved in the reductive
metabolism of t-BHP (Rush & Alberts, 1986). Pretreatment
of the cells with diphenylene iodonium, an NADPH:cyto-
chrome P-450 reductase inhibitor (Doussiere & Vignais,
1992), prevented SR 4233 reduction and cytoxicity. In a
previous study with anaerobic mouse liver microsomes,
cytochrome P-450 was implicated in the reduction of SR
4233 because carbon monoxide inhibited the liver micro-
somal (phenobarbital induced) catalysed metabolism of SR
4233 by 78-86% (Walton & Workman, 1990). DT-diaphorase
was also found to reduce SR 4233 (Riley & Workman, 1992).
However, in our study the inhibition of hepatocyte cyto-
chrome P-450 by SKF-525A or metyrapone or the inactiva-
tion of DT-diaphorase by dicumarol did not affect SR 4233
reduction. Furthermore, Lloyd et al. (1991) showed that
pretreating rat liver microsomes with metyrapone or carbon
monoxide had no effect on the production of SR 4233
radicals. This also suggests that NADPH:cytochrome P-450
reductase is the major reductase in the metabolism of SR
4233 by the uninduced liver. However our results do not rule
out the involvement of cytochrome P-450 in SR 4233 reduc-
tion in hepatocytes isolated from rats after the administration
of various cytochrome P-450 inducers.
Incubation of hepatocytes under hypoxic conditions with
fructose inhibited SR 4233-induced cell death without
affecting its reduction. Other investigators have shown that
fructose markedly increased the anaerobic production of lac-
tic acid particularly in hypoxic hepatocytes (Seglen, 1974),
the classical Pasteur effect, and that significant acidosis
developed (Iles et al., 1980). Furthermore acidosis protects
against hypoxic injury in hepatocytes (Gores et al., 1989).
Because of this the effect of monensin, an agent which
catalyses the exchange of Na+ for H+ and has been shown to
equalise intracellular pH to that of extracellular pH (Gores et
al., 1989) on the fructose protection was investigated. It was
found that monesin prevented the antidotal effect of fructose.
As perfusion of the liver with fructose also causes
acidification of the medium (Sies & Noack, 1972) the effect
of decreasing the pH of the medium on SR 4233 hypoxic
cytotoxicity was investigated. SR 4233 was found to be much
less cytotoxic to hypoxic hepatocytes at pH 6.5 than at
pH 7.4 (results not shown). This suggests that the protective
effect of fructose under hypoxic conditions can be attributed
to acidosis.
Recently Riley and Workman (1992) reported that DT-
diaphorase purified from Walker 256 rat tumour cells
catalyses a direct two- and four-electron reduction of SR
4233. However, our studies indicate that dicumarol, a highly
effective inhibitor of DT-diaphorase had no effect on SR
4233 reduction by hypoxic hepatocytes. SR 4233 radical
formation by NADPH and rat liver microsomes has also
recently been reported to be unaffected by dicumarol (Lloyd
et al., 1991). Furthermore, the NADPH:cytochrome P-450
reductase inhibitor, diphenylene iodonium, did not inhibit
DT-diaphorase (results not shown) but SR 4233 reductive
metabolism was inhibited and cytotoxicity was prevented.
Previous studies with hypoxic primary cultured
hepatocytes and CHO cells have correlated the reduction of
SR 4233 with its toxic potency. The reduction of SR 4233490 J.M. SILVA & P.J. O'BRIEN
and its toxic potency were dramatically decreased under
aerobic conditions (Baker et al., 1988; Riley & Workman,
1992). SR 4233 also induced cyanide-resistant respiration in
CHO cells (Baker et al., 1988). However, they did not ad-
dress the mechanism responsible for the aerobic toxicity of
SR 4233. Our studies with isolated hepatocytes support the
proposal that the SR 4233 free radical is formed under both
aerobic and hypoxic conditions but suggests that under
aerobic conditions SR 4233 would be cytotoxic to peroxide
susceptible cells.
The primary reason suggested for the high selectivity of SR
4233 toxicity against hypoxic cells vs aerobic cells is the back
oxidation of the SR 4233 free radical by molecular oxygen.
In the absence of oxygen the free radical is readily available
to interact with the cell's macromolecules resulting in toxi-
city. However, in our present study, an additional mechanism
was discovered involving detoxification of the radical as
result of oxidation by the mitochondrial electron transport
system. Using freshly isolated rat liver mitochondria, SR
4233 was also shown to support mitochondrial respiration in
the presence of NADH. Mitochondrial respiration was com-
pletely inhibited by KCN and antimycin A but not by
rotenone. The lack of inhibition by rotenone suggest that the
site of interaction involves ubiquinone and the cytochromes.
The reductive metabolites SR 4317 and SR 4330, did not
stimulate mitochondrial respiration. The requirement of
NADH suggests that the SR 4233 radical formed by mito-
chondrial outer membrane reductases can act as an electron
donor for the mitochondrial electron transport chain. Many
semiquinone radicals are also known to rapidly reduce
cytochrome C (O'Brien, 1991) and can therefore be detoxified
by mitochondrial oxidation. Oxidation of the free radical by
ubiquinone or cytochromes under aerobic conditions would
also prevent interaction of the radical with critical sites in the
cell (Winterbourn, 1981). Under hypoxia, any free radicals
produced from the incubation of hepatocytes with SR 4233
would no longer be detoxified by oxidation by the mitochon-
drial electron transport system as ubiquinone and cyto-
chromes are now fully reduced. In support of this theory,
hepatocytes treated with cyanide to inhibit mitochondrial
respiration by 76-78% were nearly as susceptible to SR 4233
under aerobic conditions as hypoxic hepatocytes. However it
is also possible that partly depleting hepatocyte ATP levels
with cyanide also increases SR 4233 toxicity. Although SR
4233 did not affect ATP levels in aerobic or hypoxic cells
(results not shown). Furthermore the low ATP levels in
hypoxic hepatocyte may also contribute to their marked
susceptibility to SR 4233.
In conclusion the present study using isolated hepatocytes
confirms previous work with other cell systems in establishing
SR 4233 as a selective hypoxic cell cytotoxin and also pro-
vides evidence for the first time of an oxygen dependent SR
4233-mediated oxidative stress which is nontoxic in the cells
with peroxide metabolising enzymes. At the same time it is
shown that both oxygen and mitochondria may prevent SR
4233 mediated toxicity by reoxidising the free radical
metabolite of SR 4233.
Abbreviations: GSH, glutathione; GSSG, oxidised glutathione;
HEPES, 4-(2-hydroxyethyl)-1-piperazineethane-sulfonic acid; ESR,
electron spin resonance; DMSO, dimethyldisulfoxide; BCNU, N,N-
bis(2-chloroethyl)-N-nitrosourea; KCN, potassium cyanide; s.e.,
standard error.
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